Submitted for Publication: February 3, 2015; final revision received April 19, 2015; accepted April 23, 2015.
Published Online: June 18, 2015. doi:10.1001/jamaophthalmol.2015.1790.
Study concept and design: Klufas, Itty, C. A. McCannel, T. A. McCannel.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Klufas.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Klufas.
Obtained funding: T. A. McCannel.
Administrative, technical, or material support: Klufas, C. A. McCannel, Glasgow, Moreno, T. A. McCannel.
Study supervision: Klufas, C. A. McCannel, T. A. McCannel.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr C. A. McCannel reported receiving personal fees from Dutch Ophthalmic and grants from Genentech. Dr T. A. McCannel has served as a paid consultant for Novartis and as an unpaid consultant on the Advisory Board of Impact Genetics. No other disclosures were reported.
Funding/Support: This research was supported by an unrestricted grant from Research to Prevent Blindness and the George E. and Ruth Moss Trust (support for all aspects of research at University of California, Los Angeles Ophthalmic Oncology Center). Support of vitreoretinal surgery fellowship training was provided by the Thelma and William Brand Fellow and Abe Meyer Memorial Fellow at UCLA Stein Eye Institute (Dr Klufas).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.